Your browser is no longer supported. Please, upgrade your browser.
Settings
MRNA [NASD]
Moderna, Inc.
IndexS&P 500 P/E308.22 EPS (ttm)1.25 Insider Own2.50% Shs Outstand400.00M Perf Week17.66%
Market Cap151.70B Forward P/E21.33 EPS next Y18.12 Insider Trans-54.71% Shs Float362.70M Perf Month64.96%
Income598.20M PEG18.35 EPS next Q5.96 Inst Own54.50% Short Float3.76% Perf Quarter122.66%
Sales2.73B P/S55.53 EPS this Y-26.10% Inst Trans0.49% Short Ratio1.05 Perf Half Y143.73%
Book/sh9.60 P/B40.26 EPS next Y-27.91% ROA8.50% Target Price184.92 Perf Year395.65%
Cash/sh19.71 P/C19.61 EPS next 5Y16.80% ROE19.80% 52W Range54.21 - 386.98 Perf YTD269.97%
Dividend- P/FCF30.29 EPS past 5Y- ROI-28.40% 52W High6.98% Beta-
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin92.60% 52W Low663.70% ATR21.56
Employees1300 Current Ratio1.40 Sales Q/Q24112.50% Oper. Margin23.20% RSI (14)82.36 Volatility7.14% 7.39%
OptionableYes Debt/Eq0.05 EPS Q/Q907.10% Profit Margin21.90% Rel Volume3.08 Prev Close386.51
ShortableYes LT Debt/Eq0.04 EarningsAug 05 BMO Payout0.00% Avg Volume13.04M Price414.00
Recom2.50 SMA2037.65% SMA5069.15% SMA200154.89% Volume16,289,935 Change7.11%
Jul-15-21Reiterated Jefferies Hold $170 → $250
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
Jul-13-20Initiated Jefferies Buy $90
Jun-30-20Initiated Argus Buy $80
Jun-08-20Initiated Barclays Overweight $68
Apr-30-20Initiated BMO Capital Markets Outperform $83
Mar-05-20Downgrade BofA/Merrill Buy → Neutral $32
Dec-03-19Resumed BofA/Merrill Buy
Oct-25-19Initiated ROTH Capital Buy $24
Apr-05-19Initiated Chardan Capital Markets Buy $40
Aug-04-21 11:04AM  
06:02AM  
Aug-03-21 07:10PM  
05:38PM  
05:00PM  
03:28PM  
03:06PM  
03:02PM  
02:45PM  
02:25PM  
12:39PM  
09:47AM  
09:10AM  
08:38AM  
08:15AM  
07:22AM  
04:32AM  
03:54AM  
Aug-02-21 04:29PM  
03:55PM  
02:28PM  
01:55PM  
01:05PM  
01:03PM  
12:50PM  
12:33PM  
12:02PM  
11:19AM  
10:41AM  
10:09AM  
09:22AM  
08:44AM  
06:00AM  
04:46AM  
04:24AM  
04:00AM  
03:20AM  
02:34AM  
Aug-01-21 09:00PM  
04:34PM  
09:34AM  
08:14AM  
07:40AM  
07:34AM  
06:33AM  
06:28AM  
06:15AM  
06:03AM  
06:00AM  
Jul-31-21 01:25PM  
06:35AM  
Jul-30-21 04:20PM  
01:56PM  
01:34PM  
12:31PM  
12:06PM  
09:30AM  
08:00AM  
07:39AM  
05:52AM  
02:34AM  
Jul-29-21 05:56PM  
05:45PM  
03:05PM  
02:06PM  
01:04PM  
07:02AM  
06:39AM  
06:06AM  
06:00AM  
06:00AM  
06:00AM  
Jul-28-21 03:46PM  
03:45PM  
01:51PM  
01:51PM  
01:47PM  
07:51AM  
05:52AM  
02:37AM  
02:05AM  
Jul-27-21 10:27PM  
05:37PM  
02:12PM  
10:00AM  
09:52AM  
07:48AM  
05:52AM  
02:21AM  
Jul-26-21 05:44PM  
04:41PM  
03:59PM  
02:50PM  
01:56PM  
01:05PM  
09:20AM  
09:00AM  
05:39AM  
Jul-25-21 06:31PM  
Jul-24-21 06:00AM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate, as well as Aldevron, LLC for supporting COVID-19 vaccine and additional programs in company's clinical development pipeline. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andres JuanSee remarksAug 02Option Exercise12.2115,000183,15015,000Aug 03 04:23 PM
Andres JuanSee remarksAug 02Sale360.1515,0005,402,2500Aug 03 04:23 PM
Andres JuanSee remarksJul 30Option Exercise12.215,00061,0505,000Aug 03 04:23 PM
Andres JuanSee remarksJul 30Sale346.905,0001,734,5000Aug 03 04:23 PM
Bancel StephaneChief Executive OfficerJul 29Sale351.0010,0003,510,0007,304,880Jul 30 04:31 PM
Andres JuanSee remarksJul 28Option Exercise12.215,00061,0505,000Jul 30 04:28 PM
Andres JuanSee remarksJul 28Sale332.925,0001,664,6000Jul 30 04:28 PM
Bancel StephaneChief Executive OfficerJul 28Sale332.929,0002,996,2806,191,868Jul 30 04:31 PM
Andres JuanSee remarksJul 26Option Exercise12.215,00061,0505,000Jul 27 05:29 PM
Hoge StephenPresidentJul 26Option Exercise10.905,00054,5001,614,597Jul 27 06:14 PM
Andres JuanSee remarksJul 26Sale351.995,0001,759,9500Jul 27 05:29 PM
Hoge StephenPresidentJul 26Sale351.995,0001,759,9501,609,597Jul 27 06:14 PM
Andres JuanSee remarksJul 23Option Exercise12.215,00061,0505,000Jul 27 05:29 PM
Hoge StephenPresidentJul 23Option Exercise4.2915,00064,4001,624,597Jul 27 06:14 PM
Andres JuanSee remarksJul 23Sale330.905,0001,654,5000Jul 27 05:29 PM
Hoge StephenPresidentJul 23Sale335.1315,0005,026,9551,609,597Jul 27 06:14 PM
Bancel StephaneChief Executive OfficerJul 22Sale318.5010,0003,185,0007,314,880Jul 23 09:27 AM
Andres JuanSee remarksJul 21Option Exercise12.215,00061,0505,000Jul 23 09:28 AM
Bancel StephaneChief Executive OfficerJul 21Sale299.009,0002,691,0006,204,868Jul 23 09:27 AM
Andres JuanSee remarksJul 21Sale299.005,0001,495,0000Jul 23 09:28 AM
Andres JuanSee remarksJul 19Option Exercise12.2115,000183,15015,000Jul 20 04:15 PM
Andres JuanSee remarksJul 19Sale284.4015,0004,266,0000Jul 20 04:15 PM
Andres JuanSee remarksJul 16Option Exercise12.215,00061,0505,000Jul 20 04:15 PM
Andres JuanSee remarksJul 16Sale276.515,0001,382,5500Jul 20 04:15 PM
Bancel StephaneChief Executive OfficerJul 15Sale246.6610,0002,466,6007,324,880Jul 16 09:24 AM
Andres JuanSee remarksJul 14Option Exercise12.215,00061,0505,000Jul 16 09:26 AM
Bancel StephaneChief Executive OfficerJul 14Sale237.229,0002,134,9806,215,868Jul 16 09:24 AM
Andres JuanSee remarksJul 14Sale237.225,0001,186,1000Jul 16 09:26 AM
Hoge StephenPresidentJul 13Option Exercise4.2915,00064,4001,624,597Jul 14 04:22 PM
Hoge StephenPresidentJul 13Sale238.8715,0003,583,0501,609,597Jul 14 04:22 PM
Hoge StephenPresidentJul 12Option Exercise10.905,00054,5001,614,597Jul 14 04:22 PM
Andres JuanSee remarksJul 12Option Exercise12.215,00061,0505,000Jul 14 04:23 PM
Hoge StephenPresidentJul 12Sale230.715,0001,153,5501,609,597Jul 14 04:22 PM
Andres JuanSee remarksJul 12Sale230.715,0001,153,5500Jul 14 04:23 PM
Bancel StephaneChief Executive OfficerJul 08Sale216.0710,0002,160,7007,334,880Jul 09 04:28 PM
Andres JuanSee remarksJul 07Option Exercise12.215,00061,0505,000Jul 09 04:36 PM
Bancel StephaneChief Executive OfficerJul 07Sale231.769,0002,085,8406,226,868Jul 09 04:28 PM
Andres JuanSee remarksJul 07Sale231.765,0001,158,8000Jul 09 04:36 PM
Andres JuanSee remarksJul 06Option Exercise12.215,00061,0505,000Jul 08 08:17 AM
Hoge StephenPresidentJul 06Option Exercise0.9910,0009,9001,619,597Jul 08 08:21 AM
Andres JuanSee remarksJul 06Sale229.625,0001,148,1000Jul 08 08:17 AM
Hoge StephenPresidentJul 06Sale229.6210,0002,296,2001,609,597Jul 08 08:21 AM
Hoge StephenPresidentJul 02Option Exercise0.9910,0009,9001,619,597Jul 06 04:33 PM
Hoge StephenPresidentJul 02Sale235.2110,0002,352,1001,609,597Jul 06 04:33 PM
Zaks Tal ZviChief Medical OfficerJun 30Option Exercise25.935,000129,6505,000Jul 02 04:30 PM
Zaks Tal ZviChief Medical OfficerJun 30Sale237.005,0001,185,0000Jul 02 04:30 PM
Hoge StephenPresidentJun 24Option Exercise10.905,00054,5001,614,597Jun 25 05:18 PM
Bancel StephaneChief Executive OfficerJun 24Sale213.7810,0002,137,8007,354,880Jun 25 05:14 PM
Hoge StephenPresidentJun 24Sale213.785,0001,068,9001,609,597Jun 25 05:18 PM
Zaks Tal ZviChief Medical OfficerJun 23Option Exercise25.935,000129,6505,000Jun 25 05:22 PM
Andres JuanSee remarksJun 23Option Exercise12.215,00061,0505,000Jun 25 05:26 PM
Hoge StephenPresidentJun 23Option Exercise4.2915,00064,4001,624,597Jun 25 05:18 PM
Hoge StephenPresidentJun 23Sale216.2015,0003,242,9351,609,597Jun 25 05:18 PM
Bancel StephaneChief Executive OfficerJun 23Sale219.659,0001,976,8506,248,868Jun 25 05:14 PM
Zaks Tal ZviChief Medical OfficerJun 23Sale219.655,0001,098,2500Jun 25 05:22 PM
Andres JuanSee remarksJun 23Sale219.655,0001,098,2500Jun 25 05:26 PM
Andres JuanSee remarksJun 21Option Exercise12.215,00061,0505,000Jun 23 04:47 PM
Andres JuanSee remarksJun 21Sale200.865,0001,004,3000Jun 23 04:47 PM
Bancel StephaneChief Executive OfficerJun 17Sale200.0010,0002,000,0007,364,880Jun 21 06:46 PM
Andres JuanSee remarksJun 16Option Exercise12.215,00061,0505,000Jun 21 06:58 PM
Zaks Tal ZviChief Medical OfficerJun 16Option Exercise25.935,000129,6505,000Jun 21 07:03 PM
Andres JuanSee remarksJun 16Sale200.005,0001,000,0000Jun 21 06:58 PM
Bancel StephaneChief Executive OfficerJun 16Sale200.009,0001,800,0006,259,868Jun 21 06:46 PM
Zaks Tal ZviChief Medical OfficerJun 16Sale200.005,0001,000,0000Jun 21 07:03 PM
Andres JuanSee remarksJun 14Option Exercise12.215,00061,0505,000Jun 15 04:24 PM
Hoge StephenPresidentJun 14Option Exercise5.9520,000118,9001,629,597Jun 15 04:33 PM
Andres JuanSee remarksJun 14Sale213.325,0001,066,6000Jun 15 04:24 PM
Hoge StephenPresidentJun 14Sale213.3220,0004,266,4001,609,597Jun 15 04:33 PM
Bancel StephaneChief Executive OfficerJun 10Sale216.7010,0002,167,0007,374,880Jun 11 04:06 PM
Andres JuanSee remarksJun 09Option Exercise12.215,00061,0505,000Jun 11 04:11 PM
Zaks Tal ZviChief Medical OfficerJun 09Option Exercise25.935,000129,6505,000Jun 11 04:14 PM
Bancel StephaneChief Executive OfficerJun 09Sale212.309,0001,910,7006,270,868Jun 11 04:06 PM
Andres JuanSee remarksJun 09Sale212.305,0001,061,5000Jun 11 04:11 PM
Zaks Tal ZviChief Medical OfficerJun 09Sale212.305,0001,061,5000Jun 11 04:14 PM
Andres JuanSee remarksJun 07Option Exercise12.215,00061,0505,000Jun 09 04:14 PM
Andres JuanSee remarksJun 07Sale207.045,0001,035,2000Jun 09 04:14 PM
Hoge StephenPresidentJun 03Option Exercise0.9910,0009,9001,619,597Jun 04 04:08 PM
Bancel StephaneChief Executive OfficerJun 03Sale188.8910,0001,888,9007,384,880Jun 04 04:15 PM
Hoge StephenPresidentJun 03Sale188.8910,0001,888,9001,609,597Jun 04 04:08 PM
Hoge StephenPresidentJun 02Option Exercise0.9910,0009,9001,619,597Jun 04 04:08 PM
Andres JuanSee remarksJun 02Option Exercise12.215,00061,0505,000Jun 03 04:43 PM
Zaks Tal ZviChief Medical OfficerJun 02Option Exercise25.935,000129,6505,000Jun 03 04:47 PM
Hoge StephenPresidentJun 02Sale183.9010,0001,839,0001,609,597Jun 04 04:08 PM
Bancel StephaneChief Executive OfficerJun 02Sale183.909,0001,655,1006,281,868Jun 03 04:41 PM
Andres JuanSee remarksJun 02Sale183.905,000919,5000Jun 03 04:43 PM
Zaks Tal ZviChief Medical OfficerJun 02Sale183.905,000919,5000Jun 03 04:47 PM
Andres JuanSee remarksJun 01Option Exercise12.215,00061,0505,000Jun 03 04:43 PM
Bancel StephaneChief Executive OfficerJun 01Sale183.4311,0622,029,1540Jun 03 04:41 PM
Andres JuanSee remarksJun 01Sale184.085,000920,4000Jun 03 04:43 PM
HENDERSON LORI M.General Counsel and SecretaryMay 27Option Exercise14.856,60098,0107,501May 28 08:45 AM
Bancel StephaneChief Executive OfficerMay 27Sale174.2010,0001,742,0007,394,880May 28 08:40 AM
HENDERSON LORI M.General Counsel and SecretaryMay 27Sale174.206,6001,149,720901May 28 08:45 AM
Andres JuanSee remarksMay 26Option Exercise12.215,00061,0505,000May 27 04:08 PM
Zaks Tal ZviChief Medical OfficerMay 26Option Exercise25.935,000129,6505,000May 27 04:11 PM
Zaks Tal ZviChief Medical OfficerMay 26Sale168.705,000843,5000May 27 04:11 PM
Andres JuanSee remarksMay 26Sale168.705,000843,5000May 27 04:08 PM
Bancel StephaneChief Executive OfficerMay 26Sale168.709,0001,518,3006,292,868May 28 08:40 AM
HENDERSON LORI M.General Counsel and SecretaryMay 25Option Exercise14.856,60098,0107,501May 27 04:04 PM
HENDERSON LORI M.General Counsel and SecretaryMay 25Sale166.586,6001,099,428901May 27 04:04 PM
Hoge StephenPresidentMay 24Option Exercise5.9520,000118,9001,629,597May 25 04:27 PM